603392 萬泰生物
按盤價 
72.480 -5.880 (-7.504%) | 2025/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 400,625 | -46.76% | 2,245,403 | 5,510,783 | 11,185,189 | 5,750,329 | |
| 減：營業總成本 | 464,970 | -30.83% | 2,395,621 | 3,878,717 | 5,747,909 | 3,404,115 | |
| 其中:營業成本 | 134,003 | -40.72% | 759,045 | 873,242 | 1,170,412 | 817,711 | |
| 財務費用 | (6,249) | -66.73% | (58,068) | (92,977) | (61,612) | 5,195 | |
| 資產減值損失 | (5,498) | -39.96% | (103,626) | (459,733) | (20,503) | (29,841) | |
| 公允價值變動收益 | 8,818 | 121.40% | 36,707 | 24,657 | 9,977 | 28 | |
| 投資收益 | 22,017 | -46.99% | 109,636 | 98,898 | 36,113 | 11,225 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | -- | -- | -- | -- | |
| 營業利潤 | (55,796) | -143.62% | 93,838 | 1,401,451 | 5,596,038 | 2,328,456 | |
| 利潤總額 | (57,900) | -146.08% | 67,481 | 1,393,392 | 5,582,691 | 2,324,145 | |
| 減：所得稅費用 | (3,758) | -9.31% | (41,614) | 146,887 | 719,390 | 244,931 | |
| 淨利潤 | (54,142) | -141.72% | 109,095 | 1,246,504 | 4,863,301 | 2,079,214 | |
| 減：非控股權益 | (1,365) | -133.49% | 2,859 | (1,175) | 127,506 | 57,747 | |
| 股東淨利潤 | (52,777) | -141.98% | 106,235 | 1,247,680 | 4,735,795 | 2,021,468 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.040 | -140.00% | 0.080 | 0.990 | 3.790 | 2.300 | |
| 每股派息 (元) * | -- | -- | -- | 0.320 | 1.000 | 0.200 | |
| 每股淨資產 (元) * | 9.651 | -4.50% | 9.693 | 10.015 | 13.621 | 7.357 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 06/06/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
